| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Amy D Proal | |
| Michael B VanElzakker | |||
| P2860 | cites work | A new look at cerebrospinal fluid circulation | Q21195862 |
| Myalgic encephalomyelitis: International Consensus Criteria | Q24611510 | ||
| The pathogenesis of lyme neuroborreliosis: from infection to inflammation | Q24670918 | ||
| Persistent detection of Zika virus RNA in semen for six months after symptom onset in a traveller returning from Haiti to Italy, February 2016 | Q26261633 | ||
| Zika virus in semen: a prospective cohort study of symptomatic travellers returning to Belgium | Q45323864 | ||
| Mast cells play a key role in host defense against herpes simplex virus infection through TNF-α and IL-6 production | Q45352000 | ||
| Slow clearance of measles virus RNA after acute infection | Q45402022 | ||
| Herpes-simplex virus encephalitis is characterized by an early MMP-9 increase and collagen type IV degradation | Q45410031 | ||
| Persistent elevated expression of cytokine transcripts in ganglia latently infected with herpes simplex virus in the absence of ganglionic replication or reactivation | Q45739420 | ||
| The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota. | Q46288691 | ||
| The lung microbiome in health and disease. | Q47693431 | ||
| mRNA vaccines - a new era in vaccinology | Q47736893 | ||
| Enterovirus in the chronic fatigue syndrome | Q48109791 | ||
| Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An ¹¹C-(R)-PK11195 PET Study | Q48327448 | ||
| Improvement of severe myalgic encephalomyelitis/chronic fatigue syndrome symptoms following surgical treatment of cervical spinal stenosis | Q49181667 | ||
| The diverse cellular responses of the choroid plexus during infection of the central nervous system | Q50085069 | ||
| Vaginal microbiota and susceptibility to HIV. | Q50101300 | ||
| Bartonella vinsonii subsp. berkhoffii and Bartonella henselae as potential causes of proliferative vascular diseases in animals. | Q50514391 | ||
| Beyond myalgic encephalomyelitis/chronic fatigue syndrome: an IOM report on redefining an illness. | Q50961085 | ||
| Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China | Q83767469 | ||
| Neuroimaging characteristics of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review | Q98888879 | ||
| Clinical Outcomes in Young US Adults Hospitalized With COVID-19 | Q99236398 | ||
| Modeling the Onset of Symptoms of COVID-19 | Q99237960 | ||
| Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection | Q99353970 | ||
| Neuroinvasion of SARS-CoV-2 in human and mouse brain | Q99552345 | ||
| SARS-CoV-2 and EBV coinfection | Q99584377 | ||
| Human herpesvirus 6, 7 and Epstein Barr virus reactivation in pityriasis rosea during COVID-19 | Q99706803 | ||
| Signs of Intracranial Hypertension, Hypermobility, and Craniocervical Obstructions in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | Q100300305 | ||
| Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous System | Q100386162 | ||
| Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia | Q100425353 | ||
| Long-term Health Consequences of COVID-19 | Q100500174 | ||
| Neuropathology of patients with COVID-19 in Germany: a post-mortem case series | Q100500893 | ||
| Myocarditis and inflammatory cardiomyopathy: current evidence and future directions | Q100526188 | ||
| A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model | Q100568445 | ||
| Hosts and Sources of Endemic Human Coronaviruses. | Q51146867 | ||
| Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. | Q51859209 | ||
| Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. | Q52319664 | ||
| Zika Virus Shedding in Semen of Symptomatic Infected Men. | Q52593954 | ||
| Chronic enterovirus infection in patients with postviral fatigue syndrome. | Q53815961 | ||
| Microglial control of astrocytes in response to microbial metabolites. | Q53818547 | ||
| Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome? | Q54258759 | ||
| Transcriptome analysis in whole blood reveals increased microbial diversity in schizophrenia. | Q55245667 | ||
| Viral myocarditis | Q55880215 | ||
| Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus | Q56004691 | ||
| Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) | Q57058470 | ||
| The life cycle of non-polio enteroviruses and how to target it | Q57092726 | ||
| Functional neuroanatomy of peripheral inflammatory physiology: A meta-analysis of human neuroimaging studies | Q57174266 | ||
| Herpesvirus trigger accelerates neuroinflammation in a nonhuman primate model of multiple sclerosis | Q57465755 | ||
| Intestinal barrier dysfunction orchestrates the onset of inflammatory host-microbiome cross-talk in a human gut inflammation-on-a-chip | Q57805532 | ||
| Human Endogenous Retroviruses Are Ancient Acquired Elements Still Shaping Innate Immune Responses | Q58754303 | ||
| Post-Ebola Syndrome among Ebola Virus Disease Survivors in Montserrado County, Liberia 2016 | Q59355909 | ||
| Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the Era of the Human Microbiome: Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and Immunity | Q60046972 | ||
| Corrigendum: Neuroinflammation and Cytokines in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Critical Review of Research Methods | Q64084751 | ||
| Interactions Between the Gut Microbiota and the Host Innate Immune Response Against Pathogens | Q64102240 | ||
| Viral hijacking of cellular metabolism | Q66679091 | ||
| Coronavirus infects and causes demyelination in primate central nervous system | Q67487669 | ||
| The molecular basis for a polyspecific antibody | Q72611587 | ||
| Autoantibodies against appetite-regulating peptide hormones and neuropeptides: putative modulation by gut microflora | Q80666645 | ||
| Neurotropic Enterovirus Infections in the Central Nervous System | Q26776541 | ||
| Pathogens, Commensal Symbionts, and Pathobionts: Discovery and Functional Effects on the Host | Q26795712 | ||
| Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion | Q27027234 | ||
| The neurotropic herpes viruses: herpes simplex and varicella-zoster | Q28111976 | ||
| Viruses and interferon: a fight for supremacy | Q28220397 | ||
| The human gut microbiota and virome: Potential therapeutic implications | Q28266057 | ||
| Is human herpesvirus-6 a trigger for chronic fatigue syndrome? | Q28286760 | ||
| Bacterial adaptation through loss of function | Q28534615 | ||
| Zika Virus infection of rhesus macaques leads to viral persistence in multiple tissues | Q28954543 | ||
| Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus Monkeys | Q29587262 | ||
| The many pathways of RNA degradation | Q29615760 | ||
| Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites | Q29619788 | ||
| Toxoplasmosis | Q30080013 | ||
| Mast cells and influenza a virus: association with allergic responses and beyond. | Q30375297 | ||
| Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. | Q30380365 | ||
| Fibrin Sealants in Dura Sealing: A Systematic Literature Review | Q30384006 | ||
| Metagenomic analysis of double-stranded DNA viruses in healthy adults | Q30588275 | ||
| Challenges and opportunities for brainstem neuroimaging with ultrahigh field MRI. | Q31165355 | ||
| 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. | Q33788804 | ||
| Persistent hantavirus infections: characteristics and mechanisms | Q33832091 | ||
| Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter. | Q33842381 | ||
| Borrelia burgdorferi spirochetes induce mast cell activation and cytokine release. | Q33852482 | ||
| Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression | Q33911947 | ||
| Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus | Q33993288 | ||
| Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens | Q33996240 | ||
| Borrelia spirochetes upregulate release and activation of matrix metalloproteinase gelatinase B (MMP-9) and collagenase 1 (MMP-1) in human cells | Q34005707 | ||
| Redefining chronic viral infection | Q34018497 | ||
| Myalgic encephalomyelitis--a persistent enteroviral infection? | Q34195897 | ||
| Defining the human microbiome | Q34365385 | ||
| Viral escape mechanisms--escapology taught by viruses | Q34434767 | ||
| Covid-19: Perspectives on Innate Immune Evasion | Q100991869 | ||
| SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids | Q101045728 | ||
| Coronavirus biology and replication: implications for SARS-CoV-2 | Q101051357 | ||
| Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host | Q101532842 | ||
| SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis | Q101565554 | ||
| Assessment of SARS-CoV-2 RNA Test Results Among Patients Who Recovered From COVID-19 With Prior Negative Results | Q102048287 | ||
| Prevalence of readily detected amyloid blood clots in 'unclotted' Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report | Q102140236 | ||
| Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 | Q103806429 | ||
| Long-term persistence of infectious Zika virus: Inflammation and behavioral sequela in mice | Q104267152 | ||
| Potential implications of SARS-CoV-2 oral infection in the host microbiota | Q104461325 | ||
| Coagulation abnormalities in SARS-CoV-2 infection: overexpression tissue factor | Q104478774 | ||
| Diverse Functional Autoantibodies in Patients with COVID-19 | Q104489407 | ||
| Microvascular Injury in the Brains of Patients with Covid-19 | Q104619027 | ||
| Neurological infection with SARS-CoV-2 - the story so far | Q104795309 | ||
| Pulmonary function and radiological features four months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study | Q104802424 | ||
| SARS-CoV-2 evolution during treatment of chronic infection | Q105370443 | ||
| SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms | Q106105580 | ||
| Post-acute COVID-19 syndrome | Q106292557 | ||
| Diverse Functional Autoantibodies in Patients with COVID-19 | Q107133638 | ||
| Neuroinvasion of SARS-CoV-2 in human and mouse brain | Q107392244 | ||
| SARS-CoV-2 immune evasion by variant B.1.427/B.1.429 | Q107675411 | ||
| RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study | Q107980747 | ||
| Sequelae in Adults at 6 Months After COVID-19 Infection | Q108443380 | ||
| Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies | Q108502930 | ||
| Evolution of antibody immunity to SARS-CoV-2 | Q108833281 | ||
| SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism | Q111019296 | ||
| SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis | Q111019535 | ||
| Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 Pandemic | Q111911990 | ||
| A 40-Month Follow-Up of Ebola Virus Disease Survivors in Guinea (PostEbogui) Reveals Long-Term Detection of Ebola Viral Ribonucleic Acid in Semen and Breast Milk | Q118506148 | ||
| Roles of Mitochondrial Respiratory Complexes during Infection | Q127303002 | ||
| Dysbiosis of the gut microbiota in disease. | Q34461294 | ||
| Revised Estimates for the Number of Human and Bacteria Cells in the Body | Q34537872 | ||
| The gut microbiome and the brain | Q34652493 | ||
| Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach | Q34687852 | ||
| The biology of neurotropic viruses | Q34700173 | ||
| Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) study | Q34756501 | ||
| Variation in the human immune system is largely driven by non-heritable influences | Q34998817 | ||
| Acute enterovirus infection followed by myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and viral persistence | Q35007964 | ||
| The genetic basis of Escherichia coli pathoadaptation to macrophages. | Q35069183 | ||
| HIF transcription factors, inflammation, and immunity | Q35137138 | ||
| Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome | Q35178564 | ||
| Functional signatures of oral dysbiosis during periodontitis progression revealed by microbial metatranscriptome analysis | Q35541366 | ||
| Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system | Q35567432 | ||
| Type 1 diabetes is associated with enterovirus infection in gut mucosa | Q35766884 | ||
| Vasculitis, cerebral infarction and persistent Bartonella henselae infection in a child | Q36012757 | ||
| Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome | Q36060516 | ||
| Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects | Q36402863 | ||
| Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. | Q36445604 | ||
| Persistent virus infection of muscle in postviral fatigue syndrome | Q36465600 | ||
| Competing and noncompeting activities of miR-122 and the 5' exonuclease Xrn1 in regulation of hepatitis C virus replication. | Q36583277 | ||
| Post-infectious disease syndrome | Q36722447 | ||
| From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways | Q36932850 | ||
| Interaction of hepatitis C virus with the type I interferon system | Q36935522 | ||
| Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections | Q37002972 | ||
| Human astrocytic cells support persistent coxsackievirus B3 infection | Q37254324 | ||
| Viral evasion and subversion of pattern-recognition receptor signalling | Q37319381 | ||
| Host-cell interactions with pathogenic Rickettsia species | Q37425266 | ||
| Measles virus induces persistent infection by autoregulation of viral replication | Q37435209 | ||
| Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting | Q37559641 | ||
| Prediction of molecular mimicry candidates in human pathogenic bacteria | Q37713169 | ||
| The eight human "canonical" ribonucleases: molecular diversity, catalytic properties, and special biological actions of the enzyme proteins | Q37730256 | ||
| Enteroviruses in the pathogenesis of type 1 diabetes | Q37737983 | ||
| Molecular mimicry as a mechanism of autoimmune disease | Q37957762 | ||
| Human pathogens utilize host extracellular matrix proteins laminin and collagen for adhesion and invasion of the host | Q38005762 | ||
| The mammalian secreted RNases: mechanisms of action in host defence. | Q38013042 | ||
| The global impact of the coronavirus pandemic | Q96123875 | ||
| A tissue level atlas of the healthy human virome | Q96128204 | ||
| Parkinson's disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions | Q96228268 | ||
| Human Herpesvirus 6B Greatly Increases Risk of Depression by Activating Hypothalamic-Pituitary -Adrenal Axis during Latent Phase of Infection | Q96352584 | ||
| Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2 | Q96611472 | ||
| Direct SARS-CoV-2 infection of the heart potentiates the cardiovascular sequelae of COVID-19 | Q96768947 | ||
| Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure | Q96829002 | ||
| The Lyme disease bacterium, Borrelia burgdorferi, stimulates an inflammatory response in human choroid plexus epithelial cells | Q97516763 | ||
| SARS-CoV-2 and EBV coinfection | Q97526862 | ||
| Extrapulmonary manifestations of COVID-19 | Q97531770 | ||
| Persistent Symptoms in Patients After Acute COVID-19 | Q97558381 | ||
| Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes | Q97688552 | ||
| Interplay between SARS-CoV-2 and the type I interferon response | Q98161951 | ||
| Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) | Q98170820 | ||
| Neuropathologic features of four autopsied COVID-19 patients | Q98228215 | ||
| Outcomes for Patients With COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis | Q98292905 | ||
| Co-Reactivation of Human Herpesvirus alpha Subfamily (HSV Ⅰ and VZV) in Critically Ill Patient with COVID-19 | Q98458003 | ||
| Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study | Q98470195 | ||
| Lung microbiome and coronavirus disease 2019 (COVID-19): Possible link and implications | Q98657393 | ||
| SARS-CoV-2 Infectivity and Neurological Targets in the Brain | Q98719143 | ||
| From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses | Q98777497 | ||
| Clinical symptoms between severe and non-severe COVID-19 pneumonia: A protocol for systematic review and meta-analysis | Q98883788 | ||
| Mast cells on the mind: new insights and opportunities | Q38120910 | ||
| Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes | Q38323931 | ||
| Attack, parry and riposte: molecular fencing between the innate immune system and human herpesviruses. | Q38523847 | ||
| Numerous uncharacterized and highly divergent microbes which colonize humans are revealed by circulating cell-free DNA. | Q38613374 | ||
| Hostile takeover: Manipulation of HIF-1 signaling in pathogen-associated cancers (Review). | Q38921383 | ||
| Ebola: Anatomy of an Epidemic | Q38998718 | ||
| Within host RNA virus persistence: mechanisms and consequences | Q39188201 | ||
| Revealing enterovirus infection in chronic human disorders: An integrated diagnostic approach. | Q39426840 | ||
| Acute and persistent infection of human neural cell lines by human coronavirus OC43. | Q39550114 | ||
| Epstein-Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes. | Q39686312 | ||
| Persistence of RNA viruses in the central nervous system | Q39747505 | ||
| Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer. | Q40047888 | ||
| The microbial metabolite desaminotyrosine protects from influenza through type I interferon. | Q40107499 | ||
| Chronic fatigue syndrome from vagus nerve infection: a psychoneuroimmunological hypothesis | Q40243626 | ||
| Endocarditis in adults with bacterial meningitis | Q40250795 | ||
| Acute and chronic disease caused by enteroviruses | Q40270581 | ||
| Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. | Q40510688 | ||
| Persistent infection of SARS coronavirus in colonic cells in vitro. | Q40534253 | ||
| MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment | Q40921697 | ||
| Detection of coronavirus RNA and antigen in multiple sclerosis brain | Q41121992 | ||
| Immunology. Flexibility for specificity | Q41526234 | ||
| An efficient method for long-term room temperature storage of RNA | Q41828134 | ||
| Oncogenic viruses and cancer | Q42145132 | ||
| Correction: Zika Virus infection of rhesus macaques leads to viral persistence in multiple tissues | Q42366395 | ||
| Widespread and ample peptide overlapping between HCV and Homo sapiens proteomes | Q42619634 | ||
| Activation of hypoxia-inducible factor-1 in bacillary angiomatosis: evidence for a role of hypoxia-inducible factor-1 in bacterial infections | Q43579155 | ||
| The distribution of mast cells in the human area postrema | Q44806517 | ||
| Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients | Q87143042 | ||
| Toxoplasmosis in immunosuppressed patients | Q87300546 | ||
| High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa | Q87461399 | ||
| Metabolic reprogramming of host cells upon bacterial infection: Why shift to a Warburg-like metabolism? | Q88231636 | ||
| SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor | Q88292103 | ||
| Neurotransmitter modulation by the gut microbiota | Q89106921 | ||
| The Influence of Lung Microbiota on Lung Carcinogenesis, Immunity, and Immunotherapy | Q89727343 | ||
| Silent infection of B and CD8+T lymphocytes by influenza A virus in children with tonsillar hypertrophy | Q89790275 | ||
| Parkinson's Disease: A Systemic Inflammatory Disease Accompanied by Bacterial Inflammagens | Q90049837 | ||
| Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease | Q90249928 | ||
| Microbiome and Gut Dysbiosis | Q90393608 | ||
| Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses | Q90565104 | ||
| Functional exhaustion of antiviral lymphocytes in COVID-19 patients | Q90589856 | ||
| Intra brainstem connectivity is impaired in chronic fatigue syndrome | Q91036043 | ||
| Dynamic Changes in the Microbiome and Mucosal Immune Microenvironment of the Lower Respiratory Tract by Influenza Virus Infection | Q91316680 | ||
| The gut microbiome in neurological disorders | Q91384443 | ||
| Immune-Mediated Control of a Dormant Neurotropic RNA Virus Infection | Q91593164 | ||
| Microbiota in pancreatic health and disease: the next frontier in microbiome research | Q91768615 | ||
| COVID-19: immunopathology and its implications for therapy | Q91788035 | ||
| Distinct lung microbial community states in patients with pulmonary tuberculosis | Q92027031 | ||
| Expression of HERV Genes as Possible Biomarker and Target in Neurodegenerative Diseases | Q92290184 | ||
| Effects of regulating intestinal microbiota on anxiety symptoms: A systematic review | Q92621453 | ||
| Identification of a Master Regulator of Differentiation in Toxoplasma | Q92755189 | ||
| Impaired dopamine metabolism in Parkinson's disease pathogenesis | Q93129655 | ||
| Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation | Q93138401 | ||
| Advances in Understanding the Human Urinary Microbiome and Its Potential Role in Urinary Tract Infection | Q94451622 | ||
| Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids | Q94560841 | ||
| Multiorgan and Renal Tropism of SARS-CoV-2 | Q94659963 | ||
| Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19) | Q95272165 | ||
| Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review | Q95298763 | ||
| Upregulation of Human Endogenous Retroviruses in Bronchoalveolar Lavage Fluid of COVID-19 Patients | Q95601231 | ||
| Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization | Q95629921 | ||
| IL-6: relevance for immunopathology of SARS-CoV-2 | Q95638670 | ||
| Dysregulation of type I interferon responses in COVID-19 | Q95840490 | ||
| Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review | Q96120167 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | COVID-19 | Q84263196 |
| SARS-CoV-2 | Q82069695 | ||
| long covid | Q100732653 | ||
| P304 | page(s) | 698169 | |
| P577 | publication date | 2021-01-01 | |
| P1433 | published in | Frontiers in Microbiology | Q27723481 |
| P1476 | title | Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms | |
| P478 | volume | 12 |
| Q120174730 | Acute and postacute COVID-19 outcomes for patients with rheumatoid arthritis: lessons learned and emerging directions 3 years into the pandemic |
| Q124144467 | Burnout and long COVID among the UK nephrology workforce: results from a national survey investigating the impact of COVID-19 on working lives |
| Q125759823 | Emerging Role of Kinin B1 Receptor in Persistent Neuroinflammation and Neuropsychiatric Symptoms in Mice Following Recovery from SARS-CoV-2 Infection |
| Q112704799 | Genetic alteration of human MYH6 is mimicked by SARS-CoV-2 polyprotein: mapping viral variants of cardiac interest |
| Q129111914 | Health-related quality of life in mild-to-moderate COVID-19 in the UK: a cross-sectional study from pre- to post-infection |
| Q114189396 | Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review |
| Q122827071 | Long COVID and occupational medicine practice |
| Q124986648 | Long COVID: major findings, mechanisms and recommendations |
| Q128582130 | Long Covid: A Syndemics Approach to Understanding and Response |
| Q114102053 | Lots of long COVID treatment leads, but few are proven |
| Q114662704 | Marginal BH4 deficiencies, iNOS, and self-perpetuating oxidative stress in post-acute sequelae of Covid-19 |
| Q126487317 | Neuropilin-1 Mediates SARS-CoV-2 Infection of Astrocytes in Brain Organoids, Inducing Inflammation Leading to Dysfunction and Death of Neurons |
| Q112282687 | Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia |
| Q110013384 | Persistent clotting protein pathology in Long COVID/ Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin |
| Q128955857 | Possible Role of Fibrinaloid Microclots in Postural Orthostatic Tachycardia Syndrome (POTS): Focus on Long COVID |
| Q114262029 | Representation of long COVID syndrome in the awareness of the population is revealed by Google Trends analysis |
| Q128955425 | Traumatic Brain Injury in the Long-COVID Era |
Search more.